Go to deals
Private Equity | Healthcare

AllCare has received a growth investment from Summit Partners

AllCare Family Medicine & Urgent Care (AllCare) has received a growth investment from Summit Partners.

AllCare is a provider of tech-enabled primary care medical services in retail-based settings.

Summit Partners is a private equity firm based in Boston, Massachusetts. The firm focuses on investing in technology, healthcare, life sciences and other growth industries.

Oaklins’ team in Los Angeles acted as the exclusive advisor to seller in this transaction.

Parties

Talk to the deal team

Adam Abramowitz

Managing Director
Los Angeles, United States
Oaklins Intrepid

Kyle Berkman

Associate Director
Los Angeles, United States
Oaklins Intrepid

Gavin Cutrino

Associate
Los Angeles, United States
Oaklins Intrepid

Related deals

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Learn more
Groupe JVS has completed an LBO with Capza and Bpifrance
Private Equity | TMT

Groupe JVS has completed an LBO with Capza and Bpifrance

The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more